ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares fell 5% on Tuesday . The stock traded as low as $0.41 and last traded at $0.42. 1,129,925 shares changed hands during trading, an increase of 5,459% from the average session volume of 20,327 shares. The stock had previously closed at $0.44.
ImmunoPrecise Antibodies Stock Down 5.0 %
The stock has a fifty day moving average of $0.47 and a 200-day moving average of $0.55.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- What is the Australian Securities Exchange (ASX)
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Compound Interest and Why It Matters When Investing
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Golden Cross Stocks: Pattern, Examples and Charts
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
